Home
Conditions
Pseudoxanthoma Elasticum

Clinical trial condition

Pseudoxanthoma Elasticum

Explore clinical trials studying Pseudoxanthoma Elasticum. Study availability and eligibility vary by location and protocol.

23 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Pseudoxanthoma Elasticum trial results

Recruiting

Purinergic Compounds in Pseudoxanthoma Elasticum

NCT07323082

Conditions: Cardiovascular Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Angers University hospital Angers, France

Nice University hospital Nice, France

View Trial Details

Recruiting

Impact of Optimized Recruitment and Follow-up of Patients With Pseudoxanthoma Elasticum (PXE)

NCT06636344

Conditions: Cardiovascular Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: CHU Angers Angers, France

View Trial Details

Recruiting

The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency

NCT05734196

Conditions: ATP-Binding Cassette Subfamily C Member 6 Deficiency, Arterial calcification of infancy, Autosomal Recessive Hypophosphatemic Rickets, +18 more
Locations: Rady Children's Hospital San Diego, California, United States

Boston Children's Hospital Boston, Massachusetts, United States

Nationwide Children's Hospital Columbus, Ohio, United States

The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

CHOPXE - Analysis of Choriocapillaris Flow Deficits in Patients With Pseudoxanthoma Elasticum

NCT07006649

Conditions: Cardiovascular Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations: Angers University Hospital Angers, France

View Trial Details

Recruiting

Progression Assessment of PXE-associated Alterations

NCT07048106

Conditions: Angioid Streaks, Cardiovascular Diseases, Congenital Abnormalities, +17 more
Locations: Department of Ophthalmology, University Hospital Bonn, Germany Bonn, North Rhine-Westphalia, Germany

View Trial Details

Recruiting

ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency

NCT06462547

Conditions: Arterial Calcification, Arterial calcification of infancy, Autosomal Recessive Hypophosphatemic Rickets Type 2, +17 more
Locations: Mayo Clinic Rochester, Minnesota, United States

Clinilabs Drug Development Corporation Eatontown, New Jersey, United States

Necker-Enfants Malades Hospital Paris, France

Universitätsklinikum Hamburg-Eppendorf (UKE) Hamburg, Germany

View Trial Details

Recruiting

PPI Supplementation to Fight ECtopIc Calcification in PXE

NCT04868578

Conditions: Cardiovascular Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: Angers Hospital Angers, France

Nice Hospital Nice, France

View Trial Details

Recruiting

The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum

NCT05832580

Conditions: Cardiovascular Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations: University Medical Center Utrecht Utrecht, Netherlands

View Trial Details

Completed

Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)

NCT03478839

Conditions: Arterial calcification of infancy, Autosomal Recessive Hypophosphatemic Rickets Type2, Cardiovascular Diseases, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE

NCT05030831

Conditions: ATP-Binding Cassette Subfamily C Member 6 Deficiency, Arterial calcification of infancy, Cardiovascular Diseases, +15 more
Locations: Clinilabs Eatontown, New Jersey, United States

Richmond Pharmacology Ltd (RPL) London, United Kingdom

View Trial Details

Pseudoxanthoma Elasticum

Pseudoxanthoma Elasticum trial results

Related conditions